204 related articles for article (PubMed ID: 34250834)
1. The effectiveness of Colchicine as an anti-inflammatory drug in the treatment of coronavirus disease 2019: Meta-analysis.
Golpour M; Mousavi T; Alimohammadi M; Mosayebian A; Shiran M; Alizadeh Navaei R; Rafiei A
Int J Immunopathol Pharmacol; 2021; 35():20587384211031763. PubMed ID: 34250834
[TBL] [Abstract][Full Text] [Related]
2. The efficacy of colchicine in the management of coronavirus disease 2019: A protocol for systematic review and meta-analysis.
Elshafei MN; Khalil A; El-Bardissy A; Danjuma M; Ahmed MB; Mohamed MFH
Medicine (Baltimore); 2020 Sep; 99(36):e21911. PubMed ID: 32899023
[TBL] [Abstract][Full Text] [Related]
3. Effect of Colchicine vs Usual Care Alone on Intubation and 28-Day Mortality in Patients Hospitalized With COVID-19: A Randomized Clinical Trial.
Diaz R; Orlandini A; Castellana N; Caccavo A; Corral P; Corral G; Chacón C; Lamelas P; Botto F; Díaz ML; Domínguez JM; Pascual A; Rovito C; Galatte A; Scarafia F; Sued O; Gutierrez O; Jolly SS; Miró JM; Eikelboom J; Loeb M; Maggioni AP; Bhatt DL; Yusuf S;
JAMA Netw Open; 2021 Dec; 4(12):e2141328. PubMed ID: 34964849
[TBL] [Abstract][Full Text] [Related]
4. Proactive anti-inflammatory therapy with colchicine in the treatment of advanced stages of new coronavirus infection. The first results of the COLORIT study.
Mareev VY; Orlova YA; Plisyk AG; Pavlikova EP; Akopyan ZA; Matskeplishvili ST; Malakhov PS; Krasnova TN; Seredenina EM; Potapenko AV; Agapov MA; Asratyan DA; Dyachuk LI; Samokhodskaya LM; Mershina ЕА; Sinitsyn VE; Pakhomov PV; Zhdanova EA; Mareev YV; Begrambekova YL; Kamalov АА
Kardiologiia; 2021 Mar; 61(2):15-27. PubMed ID: 33734043
[TBL] [Abstract][Full Text] [Related]
5. Can we still consider treatment with colchicine effective in SARS-COV-2 infection? Systematic review, meta-analysis, and trial sequential analysis.
De-Miguel-Balsa E; Estevan-Ortega R; Sempere-Selva MT; Latour-Pérez J; Baeza-Román A; Moya-Martinez A; Ramos-Rincon JM
Eur Rev Med Pharmacol Sci; 2021 Nov; 25(22):7151-7161. PubMed ID: 34859881
[TBL] [Abstract][Full Text] [Related]
6. Colchicine anti-inflammatory therapy for non-intensive care unit hospitalized COVID-19 patients: results from a pilot open-label, randomized controlled clinical trial.
Haroon MZ; Farooq U; Ashraf S; Zeb S; Gillani SY; Malik S; Ali R; Irshad R; Mehmood Z; Abbas Y; Masood A; Ghafoor A; Khalil AT; Asif H; Khan S; Ujjan ID; Nigar R; Livingstone S; Pascual-Figal DA; Togni S; Allergini P; Riva A; Khan A
J Physiol Pharmacol; 2022 Jun; 73(3):. PubMed ID: 36302537
[TBL] [Abstract][Full Text] [Related]
7. Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019: The GRECCO-19 Randomized Clinical Trial.
Deftereos SG; Giannopoulos G; Vrachatis DA; Siasos GD; Giotaki SG; Gargalianos P; Metallidis S; Sianos G; Baltagiannis S; Panagopoulos P; Dolianitis K; Randou E; Syrigos K; Kotanidou A; Koulouris NG; Milionis H; Sipsas N; Gogos C; Tsoukalas G; Olympios CD; Tsagalou E; Migdalis I; Gerakari S; Angelidis C; Alexopoulos D; Davlouros P; Hahalis G; Kanonidis I; Katritsis D; Kolettis T; Manolis AS; Michalis L; Naka KK; Pyrgakis VN; Toutouzas KP; Triposkiadis F; Tsioufis K; Vavouranakis E; Martinèz-Dolz L; Reimers B; Stefanini GG; Cleman M; Goudevenos J; Tsiodras S; Tousoulis D; Iliodromitis E; Mehran R; Dangas G; Stefanadis C;
JAMA Netw Open; 2020 Jun; 3(6):e2013136. PubMed ID: 32579195
[TBL] [Abstract][Full Text] [Related]
8. Colchicine treatment can improve outcomes of coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.
Hariyanto TI; Halim DA; Jodhinata C; Yanto TA; Kurniawan A
Clin Exp Pharmacol Physiol; 2021 Jun; 48(6):823-830. PubMed ID: 33719081
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory therapy for COVID-19 infection: the case for colchicine.
Reyes AZ; Hu KA; Teperman J; Wampler Muskardin TL; Tardif JC; Shah B; Pillinger MH
Ann Rheum Dis; 2021 May; 80(5):550-557. PubMed ID: 33293273
[TBL] [Abstract][Full Text] [Related]
10. Colchicine use might be associated with lower mortality in COVID-19 patients: A meta-analysis.
Elshafei MN; El-Bardissy A; Khalil A; Danjuma M; Mubasher M; Abubeker IY; Mohamed MFH
Eur J Clin Invest; 2021 Sep; 51(9):e13645. PubMed ID: 34185313
[TBL] [Abstract][Full Text] [Related]
11. The role of colchicine in the management of COVID-19: a Meta-analysis.
Elshiwy K; Amin GEE; Farres MN; Samir R; Allam MF
BMC Pulm Med; 2024 Apr; 24(1):190. PubMed ID: 38641775
[TBL] [Abstract][Full Text] [Related]
12. Effect of colchicine on mortality in patients with COVID-19 - A systematic review and meta-analysis.
Zein AFMZ; Raffaello WM
Diabetes Metab Syndr; 2022 Feb; 16(2):102395. PubMed ID: 35078098
[TBL] [Abstract][Full Text] [Related]
13. Colchicine for community-treated patients with COVID-19 (COLCORONA): a phase 3, randomised, double-blinded, adaptive, placebo-controlled, multicentre trial.
Tardif JC; Bouabdallaoui N; L'Allier PL; Gaudet D; Shah B; Pillinger MH; Lopez-Sendon J; da Luz P; Verret L; Audet S; Dupuis J; Denault A; Pelletier M; Tessier PA; Samson S; Fortin D; Tardif JD; Busseuil D; Goulet E; Lacoste C; Dubois A; Joshi AY; Waters DD; Hsue P; Lepor NE; Lesage F; Sainturet N; Roy-Clavel E; Bassevitch Z; Orfanos A; Stamatescu G; Grégoire JC; Busque L; Lavallée C; Hétu PO; Paquette JS; Deftereos SG; Levesque S; Cossette M; Nozza A; Chabot-Blanchet M; Dubé MP; Guertin MC; Boivin G;
Lancet Respir Med; 2021 Aug; 9(8):924-932. PubMed ID: 34051877
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of colchicine in patients with moderate COVID-19: A double-blinded, randomized, placebo-controlled trial.
Rahman M; Datta PK; Islam K; Haque M; Mahmud R; Mallik U; Hasan P; Haque M; Faruq I; Sharif M; Ratul RH; Azad KAK; Miah T; Rahman MM
PLoS One; 2022; 17(11):e0277790. PubMed ID: 36383611
[TBL] [Abstract][Full Text] [Related]
15. Colchicine, COVID-19 and hematological parameters: A meta-analysis.
Sarwar M; Ali Z; Fatima M; Sarfraz Z; Sarfraz A; Cherrez-Ojeda I
J Clin Lab Anal; 2021 Dec; 35(12):e24057. PubMed ID: 34708886
[TBL] [Abstract][Full Text] [Related]
16. COVID-19 in patients with gout on colchicine.
Pelechas E; Drossou V; Voulgari PV; Drosos AA
Rheumatol Int; 2021 Aug; 41(8):1503-1507. PubMed ID: 34089357
[TBL] [Abstract][Full Text] [Related]
17. Reduced mortality in COVID-19 patients treated with colchicine: Results from a retrospective, observational study.
Manenti L; Maggiore U; Fiaccadori E; Meschi T; Antoni AD; Nouvenne A; Ticinesi A; Cerundolo N; Prati B; Delsante M; Gandoflini I; Donghi L; Gentile M; Farina MT; Oliva V; Zambrano C; Regolisti G; Palmisano A; Caminiti C; Cocchi E; Ferrari C; Riella LV; Cravedi P; Peruzzi L
PLoS One; 2021; 16(3):e0248276. PubMed ID: 33760858
[TBL] [Abstract][Full Text] [Related]
18. [Proactive anti-inflammatory and anticoagulant therapy in the treatment of advanced stages of novel coronavirus infection (COVID-19). Case Series and Study Design: COLchicine versus ruxolitinib and secukinumab in open prospective randomIzed trial (COLORIT)].
Mareev VY; Orlova YA; Pavlikova EP; Akopyan ZA; Matskeplishvili ST; Plisyk AG; Seredenina EM; Potapenko AV; Malakhov PS; Samokhodskaya LM; Mershina ЕА; Sinitsyn VE; Asratyan DA; Zhdanova EA; Mareev YV; Begrambekova YL; Shatochina EA; Kamalov АА
Kardiologiia; 2020 Oct; 60(9):4-21. PubMed ID: 33131470
[TBL] [Abstract][Full Text] [Related]
19. A systematic review of the infectious complications of colchicine and the use of colchicine to treat infections.
McEwan T; Robinson PC
Semin Arthritis Rheum; 2021 Feb; 51(1):101-112. PubMed ID: 33360321
[TBL] [Abstract][Full Text] [Related]
20. The effect of colchicine on mortality outcome and duration of hospital stay in patients with COVID-19: A meta-analysis of randomized trials.
Kow CS; Lee LH; Ramachandram DS; Hasan SS; Ming LC; Goh HP
Immun Inflamm Dis; 2022 Feb; 10(2):255-264. PubMed ID: 34970856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]